Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
182.6 USD | +3.50% | +6.50% | -15.61% |
01:35pm | Wolfe Upgrades Insulet to Outperform From Peerperform With $200 Price Target | MT |
11:30am | Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $200 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.61% | 12.35B | |
-3.66% | 184B | |
-0.41% | 109B | |
-2.40% | 68.37B | |
+4.77% | 51.56B | |
+9.63% | 44.69B | |
+4.37% | 41.49B | |
+2.30% | 26.75B | |
+3.93% | 26.7B | |
+15.38% | 25.68B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- BofA Slashes Price Target on Insulet to $180 From $295, Keeps Buy Rating